Ajax Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

JAK Attack: Ajax Takes Aim at Myelofibrosis

JAK Attack: Ajax Takes Aim at Myelofibrosis
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.

New york universityNew yorkUnited statesMemorial sloan kettering cancer centerUnited kingdomMemorial hospitalEteläuomen läiOlli silvennoinenDavid weinstockAmit sinhaJakafi jakaviRoss levineBiopharma sobiMing cheahStevan hubbardEli lilly

Ajax Therapeutics Raises $95M in Series C Financing

Ajax Therapeutics Raises $95M in Series C Financing
finsmes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finsmes.com Daily Mail and Mail on Sunday newspapers.

United kingdomMartin vogelbaumAmit sinhaEli lillyMing cheahLife sciences investing at goldman sachs alternativesHead of life sciencesAjax therapeuticsGoldman sachs alternativesVivo capitalBoxer capitalWinning oneLife sciences investingVice president

Vir Biotechnology Announces Nomination of Norbert Bischofberger, Ph D and Ramy Farid, Ph D to its Board of Directors

Vir Biotechnology, Inc. today announced the nomination of Norbert Bischofberger, Ph.D. and Ramy Farid, Ph.D. to its Board of Directors at its upcoming annual meeting of stockholders on May 29, 2024.

United statesUnited kingdomKronos bioNorbert bischofbergerTechnische hochschuleRamy faridGeorge whitesideZurich eidgenVicki satoRobert perezNatural sciencesMorphic therapeutic incSynthesis groupBoard of directors morphic therapeutic incStructure therapeutics incExchange commission

Ajax Therapeutics Appoints Dr David Steensma as Chief Medical Officer

NEW YORK (BUSINESS WIRE) Aug 23, 2023

United statesKathryn morrisDavid steensmaRoss levineMartin vogelbaumLaurence joseph dineenEdwardp evansDavidp steensmaHarvard medical schoolTranslational researchDivision of hematological malignanciesNovartis institutes for biomedical researchDana farber cancer instituteDivision of hematologyDepartment of medicineInstitute physician

Ajax Therapeutics Presents Preclinical Data on AJ1-10502, a Next Generation Type II JAK2 Inhibitor, at the American Society of Hematology Annual Meeting

Ajax Therapeutics Presents Preclinical Data on AJ1-10502, a Next Generation Type II JAK2 Inhibitor, at the American Society of Hematology Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesLaurence joseph dineenKathryn morrisRoss levineAmerican society of hematologyYates networkDiscovery research at ajax therapeuticsLeukemia researchAjax therapeutics incTranslational researchWall streetAmerican societyAnnual meetingSecond generation typeDemonstrates enhanced selectivityImproved therapeutic efficacy